Opportunity to invest in Australian biotech companies


Registrations for AusBioInvest 2023, the largest investment and partnering conference in the Australian life sciences sector, have opened, and investors, company executives and delegates are invited to register today.

Creating meaningful connections between businesses and investors, this premier event enables great ideas to get the funding they need as Australian biotech companies present their investment opportunity.

This year’s programme will feature informative and insightful keynotes and panel discussions from global venture capital and investment experts sharing insights to support informed investment decisions in a complex scientific field and up to 30 presentations from public and private Australian biotechnology companies, spanning early- to late-stage, that are presenting their investment opportunity. 

Australia’s pre-eminent life science investment event offers the opportunity for potential partners and investors, including global pharma representatives, to engage with Australia’s world-leading biotech companies as they present the latest, detailed information about their business case and technologies.

The event draws key decision-makers from the investment community, including venture capitalists, private equity firms and investment bankers; as well as research analysts and representatives from pharmaceutical companies, and from governments. It merges market intelligence with investment opportunities and acts as a guide to successful biotech investment. 

AusBiotech’s premier event will lift the profile of the Australian biotechnology industry and create access to greater funding sources for local companies to develop world-class science into therapies, diagnostics and medical devices.  

Register for AusBioInvest 2023 here.

AusBioInvest 2023 is proudly sponsored by the Victorian Government.